Home › Osteosarcoma › Florida
Osteosarcoma clinical trials in Florida
10 studies for Osteosarcoma are looking for participants at sites in Florida.
Cities in Florida
- Tampa6 studies
- Gainesville4 studies
- Orlando4 studies
- St. Petersburg3 studies
- Miami3 studies
- Jacksonville3 studies
Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell Tumor
- Johns Hopkins All Children's Hospital, St. Petersburg
RecruitingPhase 2
Ages 12 to 39 · All sexes · Updated Sep 29, 2026 · NCT04616560Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
- University of Florida, Gainesville
- Nicklaus Children's Hospital, Miami
- Arnold Palmer Hospital for Children, Orlando
- and 2 more
RecruitingPhase 1/2
Up to age 30 · All sexes · Updated Sep 3, 2026 · NCT06541262Clinical Orthopaedic Data Bank (Acute and Chronic)
- UF&Shands Orthopaedics and Sports Medicine Institute, Gainesville
RecruitingObservational study
All ages · All sexes · Updated Sep 3, 2026 · NCT00411060Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas
- University of Florida, Gainesville
- Nicklaus Children's Hospital, Miami
- Arnold Palmer Hospital for Children, Orlando
- and 1 more
RecruitingPhase 1/2
Up to age 26 · All sexes · Updated Sep 3, 2026 · NCT06465199Domatinostat With Sirolimus for Relapsed, Refractory Sarcoma and Osteosarcoma
- Moffitt Cancer Center, Tampa
RecruitingPhase 1/2
Ages 12 to 40 · All sexes · Updated Sep 3, 2026 · NCT07725380Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma
- Golisano Children's Hospital of Southwest Florida, Fort Myers
- Nemours Children's Clinic-Jacksonville, Jacksonville
- Nicklaus Children's Hospital, Miami
- and 5 more
RecruitingPhase 3
Up to age 50 · All sexes · Updated Aug 25, 2026 · NCT05235165Abemaciclib for Bone and Soft Tissue Sarcoma With Cyclin-Dependent Kinase (CDK) Pathway Alteration
- Mayo Clinic, Jacksonville
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jul 28, 2026 · NCT04040205Eflornithine (DFMO) for Ewing Sarcoma and Osteosarcoma
- St. Joseph's Children's Hospital, Tampa
RecruitingPhase 2
Ages 0 to 50 · All sexes · Updated Jul 9, 2026 · NCT07321912Alpha/Beta T and B Cell Depletion With Zoledronic Acid for Solid Tumors
- University of Florida, Gainesville
RecruitingPhase 1/2
6 Months – 25 Years · All sexes · Updated Jun 30, 2026 · NCT06625190Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
- Golisano Children's Hospital of Southwest Florida, Fort Myers
- Nemours Children's Clinic-Jacksonville, Jacksonville
- Nemours Children's Hospital, Orlando
- and 2 more
RecruitingObservational study
All ages · All sexes · Updated May 18, 2026 · NCT01790152From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.